aids dementia complex/headache

Lyen an sove nan clipboard la

Chwazi kalite sòt

6 rezilta yo

Human immunodeficiency virus-related headache.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We retrospectively assessed the frequency and clinical characteristics of headache occurring in human immunodeficiency virus (HIV)-infected patients in whom we had excluded all other causes, and determined the frequency of a similar headache in an HIV-negative group. Over a 1-year period, the

Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To measure cerebrospinal fluid (CSF) tau in HIV infected patients with acute neurological episodes and to correlate the findings with the type and severity of neurological disease. METHODS CSF tau was prospectively measured in 76 consecutive HIV infected patients admitted to a specialist

[Therapy for HAM/TSP and AIDS].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

(1) We evaluated efficacy of several treatments for HTLV-I-associated myelopathy (HAM) on the basis of our study on 254 HAM patients and of literature review. Improvement of motor disability more than fair response was obtained as follows: 82% in prednisolone, 69% in interferon-alpha, 92% in

HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hallmarks of central nervous system (CNS) disease in AIDS patients are headaches, fever, subtle cognitive changes, abnormal reflexes, and ataxia. Dementia and severe sensory and motor dysfunction characterize more severe disease. Autoimmune-like peripheral neuropathies, cerebrovascular disease, and

[Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

About one third of patients with HIV infection show neurological complications with considerable morbidity and high mortality. This is an actualized review of the most important neurological manifestations resulting from primary HIV infection, from secondary opportunistic infections, or as

Memantine for dementia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Memantine is a moderate affinity uncompetitive antagonist of glutamate NMDA receptors. It is licensed for use in moderate and severe Alzheimer's disease (AD); in the USA, it is also widely used off-label for mild AD.To determine efficacy and safety of

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye